Northern Trust
ALLR

Northern Trust’s Allarity Therapeutics ALLR Stock Holding History

Northern Trust’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.1K Sell
36,534
-11,569
-24% -$16.4K ﹤0.01% 4271
2026
Q1 		$52.4K Buy
48,103
+19,161
+66% +$20.6K ﹤0.01% 4234
2025
Q4 		$31.3K Sell
28,942
-14,684
-34% -$18.7K ﹤0.01% 4346
2025
Q3 		$68.9K Buy
+43,626
New +$54.8K ﹤0.01% 4220

Other funds holding ALLR

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Northern Trust's ALLR Position: Q2 2026 in Review

Northern Trust reduced its Allarity Therapeutics (ALLR) stake by 24% in Q2 2026, selling an estimated $16.4K and leaving 36,534 shares worth $47.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4271.

Northern Trust first reported a position in ALLR in Q3 2025 and has held it in 4 quarters since. The position peaked at $68.9K in Q3 2025. 20 funds tracked by Wall St. Rank hold ALLR as of Q2 2026.

  • Northern Trust held 36,534 shares of Allarity Therapeutics worth $47.1K as of Q2 2026.
  • Northern Trust sold 11,569 Allarity Therapeutics shares in Q2 2026, an estimated $16.4K.
  • Allarity Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4271 holding.
  • Northern Trust first reported a position in Allarity Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Northern Trust's Allarity Therapeutics position peaked at $68.9K in Q3 2025.
  • 20 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.